chr6-31116174-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001264.5(CDSN):c.1441G>A(p.Ala481Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000062 in 1,612,184 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A481S) has been classified as Uncertain significance.
Frequency
Consequence
NM_001264.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDSN | NM_001264.5 | c.1441G>A | p.Ala481Thr | missense_variant | 2/2 | ENST00000376288.3 | |
PSORS1C1 | NM_014068.3 | c.-229+1283C>T | intron_variant | ENST00000259881.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDSN | ENST00000376288.3 | c.1441G>A | p.Ala481Thr | missense_variant | 2/2 | 1 | NM_001264.5 | P1 | |
PSORS1C1 | ENST00000259881.10 | c.-229+1283C>T | intron_variant | 1 | NM_014068.3 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000211 AC: 32AN: 151992Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000809 AC: 20AN: 247144Hom.: 0 AF XY: 0.0000745 AC XY: 10AN XY: 134302
GnomAD4 exome AF: 0.0000466 AC: 68AN: 1460074Hom.: 0 Cov.: 58 AF XY: 0.0000317 AC XY: 23AN XY: 726090
GnomAD4 genome AF: 0.000210 AC: 32AN: 152110Hom.: 0 Cov.: 31 AF XY: 0.000188 AC XY: 14AN XY: 74358
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2022 | The c.1441G>A (p.A481T) alteration is located in exon 2 (coding exon 2) of the CDSN gene. This alteration results from a G to A substitution at nucleotide position 1441, causing the alanine (A) at amino acid position 481 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
CDSN-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 14, 2024 | The CDSN c.1441G>A variant is predicted to result in the amino acid substitution p.Ala481Thr. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.099% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at